Development of an IgG4-RD Responder Index

Area of Science:

• Immunology
• Rheumatology
• Pathology

Background:

• Immunoglobulin G4-related disease (IgG4-RD) is a complex, multiorgan inflammatory condition with varied manifestations.
• Standardized assessment of disease activity and treatment response is lacking, hindering research and clinical management.
• The heterogeneity of IgG4-RD organ involvement necessitates validated outcome measures for consistent evaluation.

Purpose of the Study:

• To develop and refine a prototype instrument for assessing disease activity and treatment response in IgG4-related disease.
• To create a validated outcome measure for IgG4-RD, termed the IgG4-RD Responder Index (IgG4-RD RI).
• To establish a standardized method for evaluating patients with IgG4-RD across different specialties.

Main Methods:

• Development of a prototype IgG4-RD Responder Index (IgG4-RD RI) inspired by the Birmingham Vasculitis Activity Score (BVAS/WG).
• Refinement of the IgG4-RD RI through a paper case exercise by the International IgG4-RD Symposium Organizing Committee.
• Retrospective application of the revised IgG4-RD RI to fifteen IgG4-RD patients and comparison with physician global assessments.

Main Results:

• A prototype IgG4-RD Responder Index (IgG4-RD RI) was developed and refined.
• The IgG4-RD RI was applied retrospectively to assess disease activity in IgG4-RD patients.
• Scores from the IgG4-RD RI were compared to physician global assessments for validation.

Conclusions:

• The IgG4-RD Responder Index (IgG4-RD RI) represents a crucial step towards standardized outcome measurement in IgG4-related disease.
• Further validation studies are planned to confirm the utility of the IgG4-RD RI as a reliable outcome measure.
• Development of the IgG4-RD RI aims to improve the clarity of natural history, prognosis, and treatment approaches for IgG4-RD.